Heterogeneous nuclear ribonucleoprotein A2-dependent mRNA trafficking in the cytoplasm of cells.
Heterogeneous nuclear ribonucleoprotein A2-dependent mRNA trafficking in the cytoplasm of cells.
批准号:
nhmrc : 210308
负责人:
Prof Ross Smith
金额:
$23.11万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2002
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2002-01-01 至 2004-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Control of the use of DNA, gene expression, is vital to all living organisms, especially in development and disease. The information in the genes of DNA is transferred to an intermediate molecule, mRNA, in a process called transcription. The genetic information in the mRNA is subsequently used to make the protein encoded by the original gene. The switching on and off of DNA appears to be most frequently controlled at the transcription step but recently it has become apparent that there are many post-transcriptional events that govern how efficiently the genetic information is ultimately converted to protein molecules. The RNA molecules may be confined to a small region of the cell, resulting in the localization of the protein produced from it; the RNA may be rapidly degraded or stabilized; and the efficiency of production of the protein from its RNA precursor may be modulated by other molecules. It had previously been shown that the mRNA encoding a protein that is an essential structural component of central nervous system myelin is selectively transported to the regions in the cell where the myelin is made. We have identified the molecule that recognises this RNA as a protein called hnRNP A2 and shown how it selects the RNA molecules that have to be transported from the myriad of RNA moleclues in the cell at any given time. hnRNP A2 was previously thought to be confined to the nuclei of cells, but we have shown that it is also present outside the nucleus and is involved in RNA transport in a variety of cell types. hnRNP A2 appears to be directly involved in rheumatoid arthritis, lung cancer and other cancers. It has been proposed as a diagnostic test for cancer as elevated intracellular levels and circulating antibodies against this protein appear before the cancerous cells are visible under the microscope. The major aim of the proposed project is to explore the molecular mechanism by which hnRNP A2 transports RNA molecules in cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Proteomics Analysis of Interactions Between Chaperonin 10 and Cell Surface Proteins
-
批准号:LP0561097
-
项目类别:Linkage Projects
-
资助金额:$20.82万
-
财政年份:2005
-
负责人:Prof Ross Smith
-
依托单位:
Protein targeting in the brain: mRNA transport in oligodendrocytes and neurons.
-
批准号:nhmrc : 990189
-
项目类别:NHMRC Project Grants
-
资助金额:$14.94万
-
财政年份:1999
-
负责人:Prof Ross Smith
-
依托单位:
国内基金
海外基金
登录
查看更多内容
生物钟核受体Rev-erbα在缺血性卒中神经元能量代谢中的改善作用及机制研究
-
批准号:82371332
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:胡琴
-
依托单位:
Nuclear speckles支架蛋白SRRM2调控染色质高级结构的形成机制及功能研究
-
批准号:22ZR1412400
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:胡士斌
-
依托单位:
研究nuclear speckles对哺乳动物早期胚胎染色体高级结构重编程和胚胎发育的调控作用
-
批准号:--
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:柯玉文
-
依托单位:
核膜蛋白LEM4调控有丝分裂和染色体稳定性的功能和机制研究
-
批准号:31970667
-
项目类别:面上项目
-
资助金额:52.0万元
-
批准年份:2019
-
负责人:朱正茂
-
依托单位:
核孔复合体调控细胞核/叶绿体信号交流分子机制的研究
-
批准号:31970656
-
项目类别:面上项目
-
资助金额:52.0万元
-
批准年份:2019
-
负责人:齐亚飞
-
依托单位:
Mapping Quantum Chromodynamics by Nuclear Collisions at High and Moderate Energies
-
批准号:11875153
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2018
-
负责人:MARCO RUGGIERI
-
依托单位:
T细胞识别的鳞状细胞癌1型抗原增强干扰素-α抗丙型肝炎病毒作用的研究
-
批准号:81170386
-
项目类别:面上项目
-
资助金额:45.0万元
-
批准年份:2011
-
负责人:赵鸿
-
依托单位:
核素靶向示踪肿瘤新生血管作用位点研究
-
批准号:81071183
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2010
-
负责人:王荣福
-
依托单位:
精神分裂症的影像遗传易感性:基于连接异常假说的家系磁共振成像研究
-
批准号:81000580
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:阎浩
-
依托单位:
先天型成骨不全骨量失衡的病理机制及动物模型的研究
-
批准号:30973070
-
项目类别:面上项目
-
资助金额:33.0万元
-
批准年份:2009
-
负责人:张浩
-
依托单位: